tiprankstipranks
Advertisement
Advertisement

LGND Stock Latest News

Ligand Pharmaceuticals Bets Big on Royalty Growth
Company AnnouncementsLigand Pharmaceuticals Bets Big on Royalty Growth
1d ago
LGND
Ligand Pharma Advances XOMA Royalty Acquisition with Amendment
PremiumCompany Announcements
Ligand Pharma Advances XOMA Royalty Acquisition with Amendment
3d ago
8K
LGND
Ligand Pharmaceuticals’ Earnings Call Signals Scaled Royalty Push
PremiumCompany Announcements
Ligand Pharmaceuticals’ Earnings Call Signals Scaled Royalty Push
9d ago
LGND
Ligand reports Q1 adjusted EPS $1.63, consensus $1.80
PremiumThe Fly
Ligand reports Q1 adjusted EPS $1.63, consensus $1.80
14d ago
LGND
Ligand backs FY26 adjusted EPS view $8.50-$9.50, consensus $9.21
PremiumThe Fly
Ligand backs FY26 adjusted EPS view $8.50-$9.50, consensus $9.21
14d ago
LGND
Orchestra BioMed receives $15M payment from Ligand
PremiumThe FlyOrchestra BioMed receives $15M payment from Ligand
14d ago
LGND
OBIO
LGND Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
LGND Earnings this Week: How Will it Perform?
16d ago
LGND
Ligand Pharma Ends TR‑Beta License With Viking Therapeutics
Premium
Company Announcements
Ligand Pharma Ends TR‑Beta License With Viking Therapeutics
20d ago
8K
LGND
Ligand price target raised to $289 from $243 at H.C. Wainwright
PremiumThe Fly
Ligand price target raised to $289 from $243 at H.C. Wainwright
21d ago
LGND
Ligand price target raised to $252 from $235 at RBC Capital
PremiumThe Fly
Ligand price target raised to $252 from $235 at RBC Capital
23d ago
LGND
Analyst Reiterates Buy on Ligand, Lifts Price Target to $260 on Royalty Portfolio Expansion from XOMA Acquisition
PremiumRatings
Analyst Reiterates Buy on Ligand, Lifts Price Target to $260 on Royalty Portfolio Expansion from XOMA Acquisition
23d ago
LGND
Ligand price target raised to $255 from $230 at Stifel
PremiumThe Fly
Ligand price target raised to $255 from $230 at Stifel
24d ago
LGND
XOMA
Ligand price target raised to $260 from $250 at BofA
PremiumThe FlyLigand price target raised to $260 from $250 at BofA
24d ago
LGND
XOMA
Ligand Pharma to Acquire XOMA, Expands Royalty Portfolio
Premium
Company Announcements
Ligand Pharma to Acquire XOMA, Expands Royalty Portfolio
24d ago
8K
LGND
Morning Movers: Domino’s Pizza sinks following first quarter results
Premium
The Fly
Morning Movers: Domino’s Pizza sinks following first quarter results
24d ago
VZ
CPB
Ligand to acquire Xoma for $39.00 per share in cash
PremiumThe Fly
Ligand to acquire Xoma for $39.00 per share in cash
24d ago
LGND
XOMA
Ligand to buy Xoma for $39 per share, WSJ reports
PremiumThe Fly
Ligand to buy Xoma for $39 per share, WSJ reports
24d ago
LGND
XOMA
Ligand price target raised to $282 from $276 at Citi
PremiumThe Fly
Ligand price target raised to $282 from $276 at Citi
1M ago
LGND
Ligand price target raised to $243 from $239 at H.C. Wainwright
PremiumThe Fly
Ligand price target raised to $243 from $239 at H.C. Wainwright
1M ago
LGND
TVTX
This Is Why Travere Therapeutics Stock (TVTX) Surged Today
PremiumMarket NewsThis Is Why Travere Therapeutics Stock (TVTX) Surged Today
1M ago
LGND
TVTX
Ligand price target raised to $250 from $244 at BofA
Premium
The Fly
Ligand price target raised to $250 from $244 at BofA
1M ago
LGND
TVTX
Ligand partner Travere Therapeutics announces FDA approval for Filspari
Premium
The Fly
Ligand partner Travere Therapeutics announces FDA approval for Filspari
1M ago
LGND
TVTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >